Mosaicism of activatingFGFR3 mutations in human skin causes epidermal nevi
Top Cited Papers
Open Access
- 1 August 2006
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (8) , 2201-2207
- https://doi.org/10.1172/jci28163
Abstract
Epidermal nevi are common congenital skin lesions with an incidence of 1 in 1,000 people; however, their genetic basis remains elusive. Germline mutations of the FGF receptor 3 (FGFR3) cause autosomal dominant skeletal disorders such as achondroplasia and thanatophoric dysplasia, which can be associated with acanthosis nigricans of the skin. Acanthosis nigricans and common epidermal nevi of the nonorganoid, nonepidermolytic type share some clinical and histological features. We used a SNaPshot multiplex assay to screen 39 epidermal nevi of this type of 33 patients for 11 activating FGFR3 point mutations. In addition, exon 19 of FGFR3 was directly sequenced. We identified activating FGFR3 mutations, almost exclusively at codon 248 (R248C), in 11 of 33 (33%) patients with nonorganoid, nonepidermolytic epidermal nevi. In 4 of these cases, samples from adjacent histologically normal skin could be analyzed, and FGFR3 mutations were found to be absent. Our results suggest that a large proportion of epidermal nevi are caused by a mosaicism of activating FGFR3 mutations in the human epidermis, secondary to a postzygotic mutation in early embryonic development. The R248C mutation appears to be a hot spot for FGFR3 mutations in epidermal nevi.Keywords
This publication has 57 references indexed in Scilit:
- K644E/M FGFR3 Mutants Activate Erk1/2 from the Endoplasmic Reticulum through FRS2α and PLCγ-independent PathwaysJournal of Molecular Biology, 2006
- FGFR3 Dimer Stabilization Due to a Single Amino Acid Pathogenic MutationPublished by Elsevier ,2005
- Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humansHuman Molecular Genetics, 2005
- Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disordersEuropean Journal of Human Genetics, 2002
- Frequent FGFR3 mutations in urothelial papillomaThe Journal of Pathology, 2002
- Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) TumorsThe American Journal of Pathology, 2001
- Distinct Missense Mutations of the FGFR3 Lys650 Codon Modulate Receptor Kinase Activation and the Severity of the Skeletal Dysplasia PhenotypeAmerican Journal of Human Genetics, 2000
- Acanthosis nigricansPublished by Elsevier ,1994
- Epidermal nevus with transitional cell carcinomas of the urinary tractJournal of the American Academy of Dermatology, 1991
- Lethal genes surviving by mosaicism: A possible explanation for sporadic birth defects involving the skinJournal of the American Academy of Dermatology, 1987